CanBas Co., Ltd. (4575.T)
CanBas Co., Ltd., a clinical stage biopharmaceutical company, engages in the basic research and clinical development of anti-cancer drugs.
737.00+0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-26.5%
The outlook
CanBas Co., Ltd. currently reads as leaning bearish based on mixed vs its moving averages, 22% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range22% of the way from its 52-week low to high
Market cap
$14.52B
52-wk high
1,558.00
52-wk low
506.00
50-day avg
634.90
200-day avg
763.04
Trailing P/E
—